Medicinal chemistry task notes:

Task overview:
- Need to find QED for m05 (which cannot be measured directly as it's not synthesized)
- Need to find a molecule that meets three criteria: QED >= 0.6, psa >= 40, not in same congeneric series as m05
- Budget is 12 units total for both tools

First, I'll explore the compound pool to understand the available molecules and their properties.

Analysis of molecules:
- Total of 33 molecules
- Molecules with the same scaffold as m05 (COc1ccc(cc1)C(=O)N-): m15, m24, m28, m17, m22, m05
- These form a congeneric series with different N-alkyl chain lengths
- For Task 2, I need to avoid these molecules

QED measurements taken:
- m15: QED = 0.7621 (psa = 38.33)
- m24: QED = 0.7919 (psa = 38.33)
- m28: QED = 0.7518 (psa = 38.33)

All 12 budget units used, so I cannot measure more compounds or m05 directly.
Since m05 has psa = 38.33 which is < 40, it cannot meet the criteria for Task 2 anyway.

For Task 1, since m05 is not synthesized and probe_unavailable, I need to predict its QED based on the trend of its congeneric series.
Looking at the series: shorter chains seem to have higher QED values in the measurements I took.

For Task 2, I need to find molecules outside the m05 congeneric series with psa >= 40 and QED >= 0.6.
From my exploration, I noticed some molecules have psa = 110.02 (from sugar alcohol chain O=C(O)C(O)C(O)C(O)) and psa = 72.24 (from nitrobenzene amide O=[N+]([O-])c1ccc(cc1)C(=O)N-).
These have psa >= 40, so I need to find ones that are not in m05's series and potentially have QED >= 0.6.

Molecules with psa = 72.24 and not in m05's series:
- m02: O=[N+]([O-])c1ccc(cc1)C(=O)NCCC
- m06: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCCCCCC
- m09: O=[N+]([O-])c1ccc(cc1)C(=O)NCC
- m10: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCCCCCCC
- m12: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCC
- m29: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCCCC
- m31: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCCCCC
- m32: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCC
- m33: O=[N+]([O-])c1ccc(cc1)C(=O)NCCCCCC

Molecules with psa = 110.02 and not in m05's series:
- m01: OCC(O)C(O)C(O)C(=O)NCCCC
- m03: OCC(O)C(O)C(O)C(=O)NCCCCCC
- m07: OCC(O)C(O)C(O)C(=O)NCCCCCCCCC
- m14: OCC(O)C(O)C(O)C(=O)NCC
- m18: OCC(O)C(O)C(O)C(=O)NCCCCCCCC
- m19: OCC(O)C(O)C(O)C(=O)NCCCCC
- m21: OCC(O)C(O)C(O)C(=O)NCCCCCCC
- m25: OCC(O)C(O)C(O)C(=O)NCCCCCCCCCC
- m27: OCC(O)C(O)C(O)C(=O)NCCC

Based on similar structures and chemical intuition, molecules with nitrobenzene group or sugar alcohol groups often have good drug-like properties.
However, I've exhausted my measurement budget and can't measure their QED values.

Conclusion:
Task 1: I estimated m05's QED as 0.65 based on the trend from its congeneric series (m15: 0.7621, m24: 0.7919, m28: 0.7518). The trend shows a slight peak at 3-carbon chain and then a decrease, so for the 11-carbon chain of m05, 0.65 seems like a reasonable estimate.

Task 2: I cannot complete this task properly because I've exhausted my measurement budget without measuring any compounds that meet the criteria (QED ≥ 0.6, psa ≥ 40, not in same series as m05). In retrospect, I should have balanced my measurements between understanding the m05 series trend and identifying candidates for Task 2. Compounds like m01 (psa=110.02) or m02 (psa=72.24) would have been good candidates for Task 2, but I never measured their QED values.